Injectable Drug Delivery Market is expected to Hit US$ 1,258.40 Million by 2033 | Emerging Companies - Pfizer Inc, Schott AG, Terumo Corporation, Owen Mumford

DataM Intelligence has unveiled its latest report on the "Injectable Drug Delivery Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing Injectable Drug Delivery Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/injectable-drug-delivery-market?sz

The Global Injectable Drug Delivery Market size reached US$ 787.47 million in 2025 and is expected to reach US$ 1,258.40 million by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The Injectable Drug Delivery Market refers to the global industry focused on technologies, devices, and formulations used to administer medications through injections such as intravenous, intramuscular, subcutaneous, and intradermal routes. It includes prefilled syringes, autoinjectors, wearable injectors, infusion pumps, and needle-free systems used across hospitals, clinics, and homecare settings. Market growth is driven by rising chronic diseases, biologics adoption, self-administration trends, and demand for accurate, rapid, and minimally invasive drug delivery solutions that improve patient compliance and therapeutic effectiveness.

Download Free Sample Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/injectable-drug-delivery-market?sz

Recent Industry Developments: United States

✅ April 2026: Apotex Corp. partnered with Halo Pharmaceuticals to expand sterile injectable filling capacity in New Jersey, strengthening domestic injectable manufacturing and supply chain capabilities for the U.S. market.

✅ April 2026: Apotex Corp., together with Orbicular Pharmaceutical Technologies and Gland Pharma, received U.S. FDA approval for generic Infuvite Adult Injection with 180-day CGT exclusivity, boosting competition in the injectable nutrition therapy segment.

✅ February 2026: Glenmark Pharmaceuticals announced the U.S. launch of Sodium Phosphate Injection through its American subsidiary, expanding its sterile injectable portfolio for hospital and institutional healthcare channels.

Recent Industry Developments: Japan

✅ May 2026: Tanabe Pharma announced plans to introduce up to three new drugs annually in Japan while strengthening injectable and specialty drug development through international licensing and domestic R&D investments.

✅ March 2026: Cytiva signed a FlexFactory collaboration agreement with Yoshindo to establish domestic biosimilar manufacturing capabilities in Japan, supporting future injectable biologics production capacity.

✅ February 2026: The Japanese government launched a biotechnology working group focused on strengthening biopharmaceutical supply chains, regenerative medicine, and biologics manufacturing, supporting long-term injectable drug delivery innovation and domestic production capabilities.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/injectable-drug-delivery-market?sz

List of the Key Players in the Injectable Drug Delivery Market:

Becton Dickinson & Company
Baxter International, Inc
Gerresheimer AG
Pfizer Inc
Schott AG
Terumo Corporation
SHL Medical
Owen Mumford
Ypsomed
Union Medico

Emerging Market Players

ApiJect Systems
Alteogen Inc
Halozyme Therapeutics
Carmot Therapeutics

How Does Market Research Work in the Injectable Drug Delivery Market?

Market research for the Injectable Drug Delivery Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of Injectable Drug Delivery Market:

✅ April 2026: Sun Pharmaceutical Industries Acquired Organon
➠ Sun Pharmaceutical Industries announced the acquisition of Organon in a deal valued at nearly US$12 billion. The acquisition strengthens Sun Pharma's position in women's healthcare and injectable therapeutics, including long-acting injectable and biosimilar drug delivery products. The deal also expands Sun Pharma's specialty pharmaceutical portfolio globally.

✅ March 2026: embecta Announced Acquisition of Owen Mumford
➠ embecta entered into a definitive agreement to acquire Owen Mumford, a UK-based medical device company specializing in injectable drug delivery technologies, autoinjectors, and chronic disease management solutions. The acquisition is aimed at expanding embecta's injectable delivery device portfolio beyond insulin administration into broader drug delivery applications.

✅ February 2026: GSK Acquired 35Pharma
➠ GSK agreed to acquire Canadian biotech company 35Pharma for approximately US$950 million. The acquisition enhances GSK's injectable biologics pipeline, particularly in pulmonary hypertension therapies involving long-acting injectable drug candidates. The move supports GSK's expansion in advanced injectable therapeutics and specialty drug delivery systems.

Segments Covered in the Injectable Drug Delivery Market 2026:

By Device Type: Autoinjectors, Conventional injection devices, Pen Injectors, Wearable injectors, Others .

By Application: Oncology, Autoimmune Diseases, Hormonal Disorders, Orphan Disease, Others.

By Usage Pattern: Curative Care, Immunization, Other Usage Pattern.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis of the Injectable Drug Delivery Market:

⇥ North America: Leads the market due to advanced infrastructure, strong R&D investments, and early adoption of new technologies.

⇥ Europe: Shows steady growth supported by strict regulations and increasing focus on sustainability initiatives.

⇥ Asia-Pacific: Fastest-growing region driven by rapid industrialization, urbanization, and rising consumer demand in emerging economies.

⇥ Latin America: Experiences moderate growth with expansion in industrial and commercial sectors.

⇥ Middle East & Africa: Gradual market growth supported by increasing investments and improving economic conditions.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=injectable-drug-delivery-market

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Injectable Drug Delivery Market in 2025?
◆ What is the projected growth rate of the Injectable Drug Delivery Market through 2033?
◆ Who are the key players in the Injectable Drug Delivery Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Fabian
Email: fabian@datamintelligence.com
Phone USA: +1 877-441-4866
Phone UK: +44 161-870-5507
Website:https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.